logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Hypoxic Respiratory Failure

    FiltersReset Filters
    3 results

    • genosyl

      (nitric oxide)
      VERO BIOTECH, INC.
      Usage: GENOSYL® is indicated to improve oxygenation and decrease the need for extracorporeal membrane oxygenation in term and near-term neonates (over 34 weeks gestation) experiencing hypoxic respiratory failure due to pulmonary hypertension, in conjunction with ventilatory support and other appropriate treatments.

    • genosyl

      (nitric oxide)
      VERO BIOTECH, INC.
      Usage: GENOSYL® is indicated for improving oxygenation and decreasing extracorporeal membrane oxygenation needs in term and near-term neonates with hypoxic respiratory failure and pulmonary hypertension, when used alongside ventilatory support and other appropriate treatments.

    • inomax

      (nitric oxide)
      INO THERAPEUTICS LLC
      Usage: INOmax® is indicated to enhance oxygenation and decrease the necessity for extracorporeal membrane oxygenation in term and near-term neonates (over 34 weeks gestation) experiencing hypoxic respiratory failure linked to pulmonary hypertension, alongside ventilatory support and other appropriate treatments.